![Amy Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Sullivan
Keine laufenden Positionen mehr
Vermögen: 516 $ am 30.06.2026
Profil
Ms. Amy B. Sullivan was previously employed as a Chief Financial & Accounting Officer by IO Biotech, Inc., a Chief Strategy Officer by Kiadis Pharma NV, a Senior Vice President-Corporate Affairs by Keryx Biopharmaceuticals, Inc., a VP-Corporate Communications & Investor Relations by AMAG Pharmaceuticals, Inc., a Head-Corporate Communications & Investor Relations by Genencor International, Inc., and a Head-Corporate Communications & Investor Relations by Idenix Pharmaceuticals LLC.
She received her undergraduate degree from Salem International University and an MBA from Bentley University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IO BIOTECH, INC. 0,12 % | 11.04.2025 | 84 632 ( 0,12 % ) | 516 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Amy Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
| IO BIOTECH, INC. | Finanzdirektor/CFO | 31.03.2026 |
| KERYX BIOPHARMACEUTICALS | Public Communications Contact | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Investor Relations Kontakt | - |
| IDENIX PHARMACEUTICALS INC | Investor Relations Kontakt | - |
| KIADIS PHARMA N.V. | Investor Relations Kontakt | - |
Ausbildung von Amy Sullivan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salem International University
 Salem International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
